NorthWest Biotherapeutics Inc (NWBO)

[BigBioBoom]

8 months life span after recurrence. I got that from here. . Glioblastoma is an aggressive brain cancer that kills two-thirds of patients within five years. A patient's outlook with recurrence of the disease is considered to be weeks or months. ... Patients receiving VB-111 survived 15 months on average, compared to 8 months on average for patients receiving Avastin alone.Oct 1, 2015

Follow-up survival data from the Information Arm patients who did not qualify for the Phase III trial are encouraging and appear consistent with the blinded interim data from the trial. In the group of 25 Information Arm patients who had actual or apparent early tumor recurrence, the follow-up data showed that 40% of the patients lived for 3 years or more, 20% of the patients lived for 5 years or more, and 12% of the patients are still alive at 7 years.